Evidence map›Paper›PMID 42559383›Full record

ArticleSurgical neurology international2026

Bilateral deep brain stimulation for the treatment of body dysmorphic disorder and obsessive-compulsive disorder.

Andrew Ghannad, Maria Isabella Burritt St Angelo, Oleksandr Strelko, Andreas Runde, Aanya Agarwal, Nikolas A Corrales, Kelly Goldstein, Daryn K Cass, Anand V Germanwala, Douglas E Anderson

Abstract readCase Reports
In one paragraph

Article in Surgical neurology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Andrew GhannadDepartment of Neurosurgery Loyola University Medical Center, Maywood, Illinois, United States.
Maria Isabella Burritt St AngeloDepartment of Neurosurgery Loyola University Medical Center, Maywood, Illinois, United States.
Oleksandr StrelkoStritch School of Medicine, Loyola University Chicago, Illinois, United States.
Andreas RundeStritch School of Medicine, Loyola University Chicago, Illinois, United States.
Aanya AgarwalStritch School of Medicine, Loyola University Chicago, Illinois, United States.
Nikolas A CorralesStritch School of Medicine, Loyola University Chicago, Illinois, United States.
Kelly GoldsteinDepartment of Psychiatry, Rush University Medical Center, Chicago, Illinois, United States.
Daryn K CassDepartment of Neurosurgery Loyola University Medical Center, Maywood, Illinois, United States.
Anand V GermanwalaDepartment of Neurosurgery Loyola University Medical Center, Maywood, Illinois, United States.
Douglas E AndersonDepartment of Neurosurgery Loyola University Medical Center, Maywood, Illinois, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Body dysmorphic disorder (BDD) is classified under obsessive-compulsive and related disorders. BDD is characterized by intense preoccupation with the perception of deficits or flaws in appearance, with repetitive behaviors manifested by altered self-perception. These symptoms bring about significant distress, making normal functioning difficult. Patients tend to respond to a combination of cognitive and pharmacologic therapies, similar to the treatment responses of patients with other obsessive-compulsive spectrum disorders. However, in severe cases of intractable BDD when multiple modalities of therapy have failed, other treatments such as deep brain stimulation (DBS) could be considered. Case Description: A 23-year-old Caucasian male presents with a 5-year history of worsening BDD, OCD, and social phobia. A combination of cognitive behavioral therapy and standard pharmacological treatment was attempted, but symptoms progressed, leading to suicidal ideation. Ultimately, the patient elected to undergo placement of a DBS device bilaterally targeting the region bound by the ventral striatum, nucleus accumbens, and subgenual cingulate. The patient was evaluated using both the Yale-Brown Obsessive-Compulsive Scale Symptom Checklist and the Hamilton Rating Scale for Depression, both pre and postoperatively over the course of 21.5 months. Conclusion: Following DBS treatment, this patient demonstrated marked improvements in BDD-associated symptoms previously resistant to both cognitive behavioral and pharmacological therapy. This case highlights how DBS treatment can effectively improve symptoms in treatment-refractory BDD when first-line modalities have been exhausted and thus may be a potential consideration for clinical use.

Indexed as

Body dysmorphic disorderDeep brain stimulationNucleus accumbensObsessive-compulsive disorderVentral caudate

Identifiers

PMID42559383
PMCPMC13440786

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.